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Original article
Purpose: The present study aimed to elucidate the clinical characteristics of children with tuber-
ous sclerosis complex (TSC) in Korea using the Tuberous Sclerosis-Associated Neuropsychiatric 
Disorders (TAND) checklist to evaluate the comorbidities of neurocognitive and socioemotional 
problems in the Korean clinical setting. 
Methods: A survey based on the TAND checklist was administered to 58 children with TSC receiv-
ing treatment on an outpatient basis. Their medical records and test results were retrospectively 
examined. 
Results: At the time of TAND administration, 35 (64.8%) of the participants had focal epilepsy, 
three (5.6%) had generalized epilepsy, six (11.1%) had infantile spasms, and seven (13.0%) had 
Lennox–Gastaut syndrome. The most frequently reported behavioral problem was difficulty get-
ting on with other people of similar age (38/58, 65.5%). Twenty patients had received previous 
diagnoses of psychiatric disorders, six of whom had received two or more concurrent diagnoses. 
A further evaluation after testing with the TAND checklist identified new psychiatric disorders in 
two patients. Among the 35 children who underwent a formal evaluation of intelligence, 27 
(77.1%) exhibited intellectual disability. Of the school-aged patients, 65.6% (21/32) experienced 
difficulties with mathematics and 56.3% (18/32) with spelling. Difficulty dual-/multi-tasking 
(27/58, 46.6%) and low self-esteem (18, 31.0%) were the most frequent neuropsychological and 
psychosocial issues, respectively. 
Conclusion: Our findings indicate that patients with TSC tend to experience neurocognitive and 
socioemotional difficulties, and regular screening for TAND using the TAND checklist can be help-
ful for managing children with TSC in the clinical setting. 
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Introduction 
Tuberous sclerosis complex (TSC)—a representative hereditary 
neurocutaneous syndrome—is a genetic disorder affecting numer-
ous organs including the brain, eyes, heart, kidneys, lungs, and skin. 
The hallmark of TSC is the involvement of the central nervous sys-
tem (CNS) with a wide clinical spectrum varying from severe in-
tellectual disability and intractable epilepsy to normal intelligence 
and lack of seizures. CNS involvement in patients with TSC is 
mainly associated with epilepsy, intellectual disability, and autism 
spectrum disorder (ASD) [1-3]. Furthermore, many of the multi-
dimensional problems experienced by patients with TSC change 
over time, substantially affecting quality of life. Thus, an overall un-
derstanding of physical, cognitive, and mental health is necessary 
to ensure continuous and systematic management of symptoms in 
this population [3,4]. To further this aim, the neurocognitive panel 
of the 2012 International TSC Consensus Conference recom-
mended that individuals with TSC should be screened for comor-
bid conditions once per year [5]. In 2015, De Vries et al. [6] pro-
posed the Tuberous Sclerosis-Associated Neuropsychiatric Disor-
ders (TAND) checklist. 
In the present study, we aimed to investigate trends of neurocog-
nitive and socioemotional disorders in Korean children with TSC 
using a Korean version of the TAND. 
Materials and Methods 
1. Patients 
The present study included children and adolescents ( < 19 years 
of age) who were diagnosed with TSC based on established clini-
cal criteria and who underwent outpatient treatment at the Sever-
ance Children’s Hospital Department of Pediatric Neurology or 
the National Health Insurance Service Ilsan Hospital Department 
of Pediatrics Developmental Delay Clinic between March 2008 
and February 2018. The TAND was described to the parents of all 
participants, and 58 children whose parents provided consent were 
included. 
2. Methods 
The TAND checklist (United States English version) was translat-
ed into Korean in cooperation with the original authors [6]. A sur-
vey was constructed based on the translation, and medical staff 
with appropriate knowledge and experience completed the survey 
after consent was provided for study participation. The TAND 
checklist is composed of diverse items related to behavioral, psy-
chiatric, cognitive, learning, neuropsychological, and psychosocial 
issues that may occur in patients with TSC. Specifically, the version 
of the TAND checklist used in the present study contained 19 
items relevant to behavioral issues (Supplementary material). 
The study protocol conformed to the ethical guidelines of the 
World Medical Association Declaration of Helsinki and was ap-
proved by the Institutional Review Board (IRB) of Yonsei Univer-
sity Severance Hospital and National Health Insurance Service Il-
san Hospital (IRB No. 4-2018-0111 and NHIMC 2016-04-011). 
Results 
1. Patient characteristics 
Of the 58 participants, 26 (44.8%) were boys and 32 (55.2%) were 
girls, with a boy-to-girl ratio of 0.81:1. The median age at TAND 
checklist administration was 9.2 years (interquartile range, 4.1 to 
14.6). Fifty-four patients (93.1%) had been diagnosed with epilep-
sy and were receiving treatment at pediatric neurology depart-
ments. Fourteen patients (24.1%) had a history of infantile spasms 
(IS). Most patients were diagnosed with TSC based on clinical cri-
teria, although diagnoses were confirmed via TSC1 or TSC2 ge-
netic testing in 18 patients (31.0%; four with TSC1 gene mutations 
and 14 with TSC2 gene mutations).  
2. Clinical features of epilepsy in pediatric patients with 
TSC  
Of the 58 participants, 54 (93.1%) had a history of epilepsy treat-
ment, including 25 boys (46.3%) and 29 girls (53.7%; boy-to-girl 
ratio, 0.86:1). The median age at first seizure was 0.7 years (inter-
quartile range, 0.3 to 2.0) (Table 1). 
At TAND checklist administration, three patients (5.6%) were 
seizure-free and required no further treatment for epilepsy, where-
as 35 patients (64.8%) were undergoing relevant treatment for fo-
cal epilepsy, and three patients (5.6%) were for generalized epilep-
sy. 
Six children (11.1%) had IS and seven (13.0%) had Lennox–
Gastaut syndrome (LGS) at the time of the study (Table 1). 
When the TAND checklist was administered, one-fifth of the 
patients (n = 17, 21.5%) were experiencing intractable seizures at 
least once daily. The mean number of drugs used at the time of the 
study was 2.1 ± 1.32 (range, 0 to 6). Thirteen patients (24.1%) had 
attempted to follow a ketogenic diet (KD), and 15 (27.8%) had 
undergone epilepsy surgery. Three patients had both attempted to 
follow a KD and had undergone epilepsy surgery (Table 1). 
3. TAND checklist results 
1) Behavioral level 
Of the 19 behavior-related items, challenges interacting with peers 
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was the most frequently reported (38/58, 65.5%), followed by lan-
guage delay or impairment (36/58, 62.1%). More than half of all 
patients experienced inattentiveness (31/58, 53.4%) and mood 
swings (29/58, 50.0%) (Fig. 1A). Twenty-four patients (24/58, 
41.3%) have had further evaluation or support for related prob-
lems and 14 parents of participants (14/58, 24.1%) wished further 
evaluation for their children. 
2) Psychiatric level 
Twenty patients had previously been diagnosed with a specific 
psychiatric disorder based on diagnostic criteria and six patients 
had more than two disorders (Fig. 1B). There were seven patients 
(12.1%) with attention deficit hyperactivity disorder (ADHD), six 
(10.3%) with ASD, four (6.8%) with anxiety disorder including 
panic, phobia, separation anxiety disorder, while three had depres-
sive disorder. Two patients had been diagnosed with obsessive 
compulsive disorder (OCD) and one patient had schizophrenia 
(SPR). Two children had been diagnosed with ADHD, depressive 
disorder, and anxiety disorder and had begun treatment for their 
respective conditions based on further evaluations after adminis-
tration of the TAND checklist. 
3) Intellectual level 
Formal evaluation and confirmation of intelligence was possible in 
35 patients (60.3%). Of these patients, five (14.3%) exhibited nor-
mal intelligence (intelligence quotient [IQ] > 80), two (5.7%) had 
borderline intellectual ability (IQ, 70 to 80), and the rest (80.0%) 
had intellectual disability in various degrees (Fig. 2). 
Fifty-three of the 58 parents of participants responded to ques-
tions regarding concern for their child’s intellectual ability, with 45 
guardians (84.9%) expressing concerns. Additionally, 34 guardians 
(58.6%) intended to seek further evaluation or support regarding 
the child’s cognitive function. These results indicate that the 
TAND checklist motivated approximately 60% of guardians to 
seek additional evaluation or support for previously unidentified 
issues relevant to intellectual disability.  
4) Academic level 
Thirty-two participants were of school age ( > 6 years of age). 
Twenty-one participants (65.6%) experienced challenges with 
mathematics, 18 (56.3%) had difficulties with spelling, and 15 
(28.2%) each with reading and writing (Fig. 1B). None of the five 
patients with normal intelligence reported learning difficulties. 
Twenty participants were reported to had been considered for ad-
ditional support in school such as further help or an individual ed-
ucational plan. 
5) Neuropsychological level 
The most commonly impaired function was multi-tasking (27/58, 
46.6%), followed by executive functioning skills (26/58, 44.8%), 
and attention/visuospatial task performance (23/58 for each abili-
ty, 39.7%) (Fig. 1A). One of the five patients with normal intelli-
gence experienced challenges with multi-tasking, whereas the re-
maining patients with normal intelligence did not report neuropsy-
chological difficulties. 
6) Psychosocial level 
Low self-esteem was reported by 18 patients (31.0%), very high 
levels of stress between parents leading to significant relationship 
difficulties were reported by 13 patients (22.4%), and very high 
levels of stress in families were reported by 12 patients (20.7%) 
(Fig. 1B). Even four patients with normal intelligence who had no 
neuropsychological difficulties in other levels reported low self-es-
teem or stress in families. 




 Male 25 (46.3)
 Female 29 (53.7)
Age at seizure onset (yr) 0.7 (0.3-2.0)
Type of epilepsy at TAND checklist administration
 Focal epilepsy 35 (64.8)
 Generalized epilepsy 3 (5.6)
 Infantile spasms 6 (11.1)
 Lennox–Gastaut syndrome 7 (13.0)
 Improved with treatment 3 (5.6)
Seizure frequency at TAND checklist administration
 Seizure-free state (>1 yr) 29 (53.7)
 Yearly seizures 2 (3.7)
 Monthly seizures 6 (11.1)
 Weekly seizures 8 (14.8)
 Daily seizures 9 (16.7)
Treatment modalities
 AEDs only 28 (51.9)
 Mean no. of AEDs at TAND checklist administration 
(range)
2.1 (0.0–6.0)
 Ketogenic diet history 13 (24.1)
 Epilepsy surgery history 15 (27.8)
Values are presented as number (%) or median (interquartile range).
TAND, Tuberous Sclerosis-Associated Neuropsychiatric Disorders; AED, 
anti-epileptic drug.
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Difficulties getting on with other people of similar age
Absent or delayed onset of language to communicate
Difficulty paying attention or concentrating
Mood swings
Very rigid or inflexible or not liking change on routines
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Fig. 1. Detailed results of the Tuberous Sclerosis-Associated Neuropsychiatric Disorders checklist in 58 pediatric participants with 
tuberous sclerosis complex. (A) Number of participants per item for the behavioral and neuropsychological levels. (B) Number of 
participants per item for the psychiatric, academic, and psychological levels. ASD, autism spectrum disorder; ADHD, attention deficit 
hyperactivity disorder; IEP, individual educational plan.
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Discussion 
Curatolo et al. [2] described TAND as an umbrella term encom-
passing diverse impairments at the behavioral, psychiatric, cogni-
tive, learning, neuropsychological, and psychosocial levels. In the 
present study we tried to focus on diverse aspects of TSC patients 
not only on epilepsy but also on other neuropsychiatric problems 
using the Korean version of TAND checklist. We directly commu-
nicated with the original authors of TAND-related articles [6,7] 
and translated with back-translation process over 10 months and at 
last administered it to 58 Korean children with TSC. We observed 
considerable challenges in behavioral, psychiatric, cognitive, learn-
ing, neuropsychological, and psychosocial functioning in TSC pa-
tients using it. 
TSC is known to be associated with developmental delays, as 
well as cognitive, learning, and behavioral disorders that are inde-
pendent of epilepsy [1,2,8,9]. But these TAND characteristics are 
not frequently evaluated, treated, or managed in a systematic fash-
ion, resulting in a gap between the clinical needs of patients and 
available treatment options. To reduce the treatment gap, neuro-
psychiatric assessment should be performed at each lifespan stage 
in clinical setting in treating TSC patients [6,10]. 
Diverse behavioral problems can be seen on TSC patients and 
shared experience of these characteristics can be helpful to dealing 
with these patients for the parents and clinicians. 
In psychiatric level, ASD occurs in 40% to 50% of patients, and 
30% to 50% of patients are diagnosed with ADHD. Previous stud-
ies have also reported that psychiatric disorders such as anxiety/
panic disorder, depression, OCD, and SPR are often comorbid 
with TSC [2]. Comparing with that, in the present study, ASD, 
ADHD, and anxiety occurred in 10.3% (6/58), 12.1% (7/58), and 
6.8% (4/58) of patients, respectively. These values are much lower 
than those reported by previous studies, although we suspect un-
derreporting due to limited awareness of psychiatric disorders in 
the patient population. Future studies should aim to enhance 
awareness of comorbid psychiatric disorders in pediatric patients 
with TSC using screening tests such as the TAND checklist; subse-
quent intensive evaluation and intervention should then occur as 
necessary. 
In intellectual level, 28 (80.0%) of the 35 patients whose IQ was 
assessed with a formal intelligence test had intellectual disability in 
the present study. Intellectual disabilities are reported that majorly 
correlated with intractable epilepsy in TSC patients, 60.7% of these 
patients had intractable epilepsy with previous treatments includ-
ing using ≥ 3 drugs, KD, or surgery. Cognitive impairment in TSC 
patients is revealed to be more severe in patients whose seizures 
begin at an earlier age, those with drug-resistant epilepsy, those 
who experience various seizure types, and those with more brain 
tubers [11-13]. Cognitive impairment also tends to be more severe 
as the number of drugs increased. A similar trend was also ob-
served in patients who had attempted to follow a KD or had under-
gone surgery for drug-resistant epilepsy, and in patients diagnosed 
with IS or LGS [14,15]. One of the seven patients with normal or 
borderline intelligence had no history of epilepsy, whereas the rest 
were confirmed to have focal epilepsy that was well-controlled 
with drug therapy. 
Learning disability belongs to the different aspect of TSC. In ac-
ademic issue, learning disability occurs in 30% of school-aged pa-
tients with TSC. Even if intelligence is normal, patients often expe-
rience challenges with reading, writing, arithmetic, and spelling, 
which necessitates individualized learning plans [2,6]. Although 
none of the seven patients with normal intelligence reported learn-
ing-related problems, many patients with cognitive impairment did 
experience learning challenges. More than half of school-aged pa-
tients with TSC experienced challenges with mathematics or spell-
ing (65.6% and 56.3%, respectively), and as many as 28.2% of pa-
tients reported difficulties with reading and writing. These findings 
are consistent with previously published results [3,6,8]. 
Some studies have previously revealed the following frequently 








Fig. 2. Intellectual level of 32 school-age participants with tuberous sclerosis complex.
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memory impairment, challenges with maintaining or shifting at-
tention, challenges with multi-tasking, and impairments in visuo-
spatial working memory, executive function, and orientation [2,6]. 
We also observed that patients experienced challenges with 
multi-tasking (27/58, 46.6%), as well as impairments in executive 
function (26/58, 44.8%), attentiveness (23/58, 39.7%), and visu-
ospatial task performance (23/58, 39.7%). An examination of cas-
es in which formal neuropsychological tests were performed fol-
lowing evaluation with the TAND checklist revealed a discrepancy 
between neuropsychological conditions reported by guardians on 
the TAND checklist and the results of formal tests. 
The limitations of this study include its small sample size and 
one-time point assessment. Larger longitudinal observations and 
correlations between the TAND checklist and formal neuropsy-
chological evaluations could support more reliable and useful in-
formation for the assessment and treatment of individuals of TSC. 
Accordingly, future studies should investigate the correlation be-
tween the results of the TAND checklist and formal neuropsycho-
logical tests to identify the source of this discrepancy. 
In this study, we performed the first translation and administra-
tion of the TAND checklist Korean version. The screening results 
will aid clinicians in referring patients for further evaluation and in 
subsequent treatment planning. The translation of the checklist in 
Korean will also aid in across country comparisons. Future studies 
should investigate the validity of the TAND checklist by examining 
correlations between TAND responses and the results of formal 
neuropsychological tests. 
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